Dierk Neugebauer
Corporate Officer/Principal bij Bristol-Myers Squibb GmbH & Co. KGaA
Profiel
Dierk Neugebauer is currently the Vice President-Market Access Germany at Bristol-Myers Squibb GmbH & Co. KGaA since 2020.
He previously worked as a Director at cerbomed GmbH.
Actieve functies van Dierk Neugebauer
| Bedrijven | Functie | Begin |
|---|---|---|
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Corporate Officer/Principal | 01-01-2011 |
Eerdere bekende functies van Dierk Neugebauer
| Bedrijven | Functie | Einde |
|---|---|---|
cerbomed GmbH
 cerbomed GmbH Medical SpecialtiesHealth Technology cerbomed GmbH manufactures and supplies medical devices for treating epilepsy. It offers NEMOS, a transcutaneous vagus nerve stimulation unit that treats epilepsy patients. The company was founded by Stefan Dietrich and Timo Freitag in 2005 and is headquartered in Erlangen, Germany. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
cerbomed GmbH
cerbomed GmbH Medical SpecialtiesHealth Technology cerbomed GmbH manufactures and supplies medical devices for treating epilepsy. It offers NEMOS, a transcutaneous vagus nerve stimulation unit that treats epilepsy patients. The company was founded by Stefan Dietrich and Timo Freitag in 2005 and is headquartered in Erlangen, Germany. | Health Technology |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Health Technology |
